| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 342 |
| 1 | ADALIMUMAB | 318 |
| 2 | PREDNISONE | 318 |
| 3 | METHOTREXATE | 299 |
| 4 | ETANERCEPT | 239 |
| 5 | INFLIXIMAB | 164 |
| 6 | FOLIC ACID | 161 |
| 7 | AZATHIOPRINE | 155 |
| 8 | TOFACITINIB | 134 |
| 9 | RITUXIMAB | 132 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | 1 | 0.0769 |
| 1 | CONCIZUMAB | 2 | 0.0444 |
| 2 | ANTIBACTERIAL HAND WIPES | 13 | 0.0389 |
| 3 | BORIC ACID | 13 | 0.0366 |
| 4 | BENZALKONIUM CHLORIDE 0.13% | 13 | 0.0346 |
| 5 | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE | 1 | 0.0333 |
| 6 | BENZALKONIUM CHLORIDE | 13 | 0.0296 |
| 7 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE | 1 | 0.0250 |
| 8 | POLYHEXAMETHYLENE BIGUANIDE HYDROCHLORIDE | 1 | 0.0244 |
| 9 | HYPROMELLOSE 2208 (15000 MPA.S) | 1 | 0.0233 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 481 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 444 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 298 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 224 |
| 4 | Vitamin B12 [EPC] | 174 |
| 5 | Vitamin C [EPC] | 172 |
| 6 | Vitamin D [EPC] | 169 |
| 7 | Purine Antimetabolite [EPC] | 159 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 147 |
| 9 | Proton Pump Inhibitor [EPC] | 122 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue Factor Pathway Inhibitor Antagonist [EPC] | 2 | 0.0444 |
| 1 | Adrenocorticotropic Hormone [EPC] | 6 | 0.0067 |
| 2 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 3 | Polyene Antimicrobial [EPC] | 1 | 0.0024 |
| 4 | Provitamin D2 Compound [EPC] | 69 | 0.0023 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 9 | 0.0020 |
| 6 | Purine Antimetabolite [EPC] | 159 | 0.0016 |
| 7 | Aminosalicylate [EPC] | 118 | 0.0012 |
| 8 | Type I Interferon Receptor Antagonist [EPC] | 2 | 0.0010 |
| 9 | Quinolone Antimicrobial [EPC] | 10 | 0.0010 |